Literature DB >> 11908269

Omenn syndrome in the context of other B cell-negative severe combined immunodeficiencies.

Anna Villa1, Christina Sobacchi, Paulo Vezzoni.   

Abstract

Severe combined immunodeficiencies represent a heterogeneous group of hereditary defects of the immune system that affect both T and B cells and whose etiology has only recently begun to be understood. A portion of these SCID patients bear a defect in either of the two recombination-activating genes, Rag-1 or Rag-2, while others have mutations in a newly identified gene, Artemis. Omenn syndrome is an unusual severe immunodeficiency with T cells but no B cells, and peculiar features also due to a defect in Rag-1 or Rag-2 genes. All these three forms are characterized by an impairment of the VDJ recombination, the process that insures the somatic diversification of immunoglobulin and T cell receptor-encoding genes. Recent findings have enabled us to better understand the pathophysiology of these three immunodeficiencies, which affect the V(D)J recombination process to a different extent and in different ways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11908269

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  5 in total

1.  Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model.

Authors:  Khie Khiong; Masaaki Murakami; Chika Kitabayashi; Naoko Ueda; Shin-ichiro Sawa; Akemi Sakamoto; Brian L Kotzin; Stephen J Rozzo; Katsuhiko Ishihara; Marileila Verella-Garcia; John Kappler; Philippa Marrack; Toshio Hirano
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

2.  ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells.

Authors:  Sarah A Maas; Nina M Donghia; Kathleen Tompkins; Oded Foreman; Kevin D Mills
Journal:  BMC Biol       Date:  2010-10-27       Impact factor: 7.431

3.  Homologous recombination is necessary for normal lymphocyte development.

Authors:  Lura B Caddle; Muneer G Hasham; William H Schott; Bobbi-Jo Shirley; Kevin D Mills
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

4.  Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype.

Authors:  Irit Tirosh; Yasuhiro Yamazaki; Francesco Frugoni; Francesca A Ververs; Eric J Allenspach; Yu Zhang; Siobhan Burns; Waleed Al-Herz; Lenora Noroski; Jolan E Walter; Andrew R Gennery; Mirjam van der Burg; Luigi D Notarangelo; Yu Nee Lee
Journal:  J Allergy Clin Immunol       Date:  2018-06-18       Impact factor: 10.793

Review 5.  Understanding inborn errors of immunity: A lens into the pathophysiology of monogenic inflammatory bowel disease.

Authors:  Jodie Deborah Ouahed
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.